Table 2.

Overview of treatment options for heavy menstrual bleeding

Hormonal?Amenorrhea rate, %Contraceptive efficacy, %VTE risk?Reversible?
Levonorgestrel intrauterine system Yes—progesterone 50 >99 No Yes 
Subdermal implant Yes—progesterone 20 >99 No* Yes 
DMPA Yes—progesterone 68 >99 Yes Yes 
Progestin-only pill Yes—progesterone 5-10 90 (typical use) to 99 (with perfect use)38  No Yes 
Combined hormonal contraceptives Yes—estrogen and progesterone Variable 90 (typical use) to >99 (with perfect use)38  Yes Yes 
Nonhysterectomy procedures No Variable39  Not effective (alternative contraception required) No Usually not 
Hysterectomy No 100 100 Temporary around the time of surgery No 
Tranexamic acid/antifibrinolytics No Not applicable Not effective (alternative contraception required) Unclear Yes 
Hormonal?Amenorrhea rate, %Contraceptive efficacy, %VTE risk?Reversible?
Levonorgestrel intrauterine system Yes—progesterone 50 >99 No Yes 
Subdermal implant Yes—progesterone 20 >99 No* Yes 
DMPA Yes—progesterone 68 >99 Yes Yes 
Progestin-only pill Yes—progesterone 5-10 90 (typical use) to 99 (with perfect use)38  No Yes 
Combined hormonal contraceptives Yes—estrogen and progesterone Variable 90 (typical use) to >99 (with perfect use)38  Yes Yes 
Nonhysterectomy procedures No Variable39  Not effective (alternative contraception required) No Usually not 
Hysterectomy No 100 100 Temporary around the time of surgery No 
Tranexamic acid/antifibrinolytics No Not applicable Not effective (alternative contraception required) Unclear Yes 
*

One study showed a nonsignificant increased risk of VTE among those using the etonogestrel implant, while other studies have shown no increased risk.19–21 

Close Modal

or Create an Account

Close Modal
Close Modal